What is the first treatment for pemphigus vulgaris?

Pemphigus vulgaris is an autoimmune blistering disease in which the immune system targets connections between skin cells. Fragile blisters and raw erosions can affect the skin, mouth or other moist linings, so treatment aims to stop new lesions and allow existing areas to heal.

Oral corticosteroid treatment reduces inflammation and the immune response throughout the body. Biologic therapy targets a specific immune pathway and may be used when the disease is extensive, difficult to control or requires a steroid-sparing plan. A dermatologist usually individualises treatment to disease activity and general health.

Take prescribed medicine exactly as directed and do not stop an oral corticosteroid suddenly without medical guidance. Use gentle skin care, avoid rubbing blisters and choose soft foods if mouth sores make eating uncomfortable. Tell the treating team about infections, new medicines and any history of bone, stomach, blood-sugar or blood-pressure problems.

Keep a record of new blisters, mouth pain, swallowing difficulty and medicine effects. Ask whether biologic therapy is appropriate and what screening or monitoring is needed before it begins.

Contact the dermatology team promptly when new blisters continue, sores are spreading or treatment causes concerning effects. Seek urgent care for inability to drink, severe mouth or throat pain, breathing difficulty, extensive raw skin, fever or signs of infection.

How active is my pemphigus vulgaris, and what is the starting treatment goal? How will oral corticosteroid treatment be monitored? Could biologic therapy reduce steroid exposure for me? Which wound-care and mouth-care products are safe?